ASX - Delayed Quote AUD

EZZ Life Science Holdings Limited (EZZ.AX)

Compare
4.6800 -0.2800 (-5.65%)
As of 11:56 AM GMT+11. Market Open.
Loading Chart for EZZ.AX
DELL
  • Previous Close 4.9600
  • Open 4.9100
  • Bid 4.6200 x --
  • Ask 4.7000 x --
  • Day's Range 4.5000 - 4.9100
  • 52 Week Range 0.4500 - 4.9700
  • Volume 120,382
  • Avg. Volume 192,447
  • Market Cap (intraday) 207.901M
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) 29.25
  • EPS (TTM) 0.1600
  • Earnings Date --
  • Forward Dividend & Yield 0.03 (0.50%)
  • Ex-Dividend Date May 16, 2024
  • 1y Target Est --

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand. The company also offers its products online. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Lidcombe, Australia.

ezzlife.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: EZZ.AX

View More

Performance Overview: EZZ.AX

Trailing total returns as of 10/7/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EZZ.AX
630.24%
S&P/ASX 200 [XJO]
7.80%

1-Year Return

EZZ.AX
642.83%
S&P/ASX 200 [XJO]
17.66%

3-Year Return

EZZ.AX
852.04%
S&P/ASX 200 [XJO]
12.76%

5-Year Return

EZZ.AX
588.24%
S&P/ASX 200 [XJO]
0.00%

Compare To: EZZ.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EZZ.AX

View More

Valuation Measures

Annual
As of 10/4/2024
  • Market Cap

    220.34M

  • Enterprise Value

    201.44M

  • Trailing P/E

    30.67

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.22

  • Price/Book (mrq)

    10.33

  • Enterprise Value/Revenue

    3.03

  • Enterprise Value/EBITDA

    19.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.48%

  • Return on Assets (ttm)

    28.12%

  • Return on Equity (ttm)

    38.79%

  • Revenue (ttm)

    66.44M

  • Net Income Avi to Common (ttm)

    6.96M

  • Diluted EPS (ttm)

    0.1600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.58M

  • Total Debt/Equity (mrq)

    0.58%

  • Levered Free Cash Flow (ttm)

    4.65M

Research Analysis: EZZ.AX

View More

Revenue vs. Earnings

Revenue 22.37M
Earnings 2.91M
 

Analyst Price Targets

 

Company Insights: EZZ.AX

People Also Watch